Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
MedPlus Health Services Ltd. ( (IN:MEDPLUS) ) has provided an announcement.
MedPlus Health Services Ltd. announced that its subsidiary, Optival Health Solutions Private Limited, has received suspension orders for drug licenses at two of its stores. The suspensions, issued under the Drugs and Cosmetics Act, 1940, will affect stores in Andhra Pradesh and Karnataka, potentially resulting in a revenue loss of approximately Rs 3.04 lacs. These suspensions highlight regulatory challenges and could impact the company’s financial operations and market positioning.
More about MedPlus Health Services Ltd.
MedPlus Health Services Ltd. operates in the healthcare industry, primarily focusing on retail pharmacy services. The company is known for its extensive network of pharmacy stores across India, offering a wide range of pharmaceutical products and health-related services.
YTD Price Performance: -6.88%
Average Trading Volume: 6,909
Current Market Cap: 90.08B INR
For a thorough assessment of MEDPLUS stock, go to TipRanks’ Stock Analysis page.